Profilo
Dr. Christophe Reymond is Chief Scientific Officer at Anergis SA.
Dr. Reymond was previously employed as an Assistant Professor by University of Lausanne, Chief Scientific Officer by Dictagene, and Researcher by University of California San Diego.
Precedenti posizioni note di Christophe Reymond
| Società | Posizione | Fine |
|---|---|---|
| Dictagene | Fondatore | 01/01/2005 |
| University of Lausanne | Corporate Officer/Principal | 01/01/2001 |
| University of California San Diego | Corporate Officer/Principal | - |
Anergis SA
 Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Health Technology |
| Dictagene |
- Borsa valori
- Insiders
- Christophe Reymond